Biomarin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?
BIOMARIN PHARM has three approved drugs.
There are sixteen US patents protecting BIOMARIN PHARM drugs.
There are one hundred and sixty-nine patent family members on BIOMARIN PHARM drugs in thirty-one countries and nine supplementary protection certificates in nine countries.
Summary for Biomarin Pharm
| International Patents: | 169 |
| US Patents: | 16 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Biomarin Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-001 | Nov 19, 2021 | RX | Yes | Yes | 11,911,446 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-001 | Nov 19, 2021 | RX | Yes | Yes | RE48267 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-002 | Nov 19, 2021 | RX | Yes | Yes | 11,590,204 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | POWDER;ORAL | 205065-002 | Oct 27, 2015 | AB | RX | Yes | No | 9,216,178*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | AB | RX | Yes | Yes | RE43797*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-002 | Nov 19, 2021 | RX | Yes | Yes | 8,198,242 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Powder for Oral Solution | 100 mg per packet | ➤ Subscribe | 2015-11-09 |
| ➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2014-05-30 |
| ➤ Subscribe | Powder for Oral Solution | 500 mg/packet | ➤ Subscribe | 2016-12-20 |
International Patents for Biomarin Pharm Drugs
Supplementary Protection Certificates for Biomarin Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2432489 | 2290005-4 | Sweden | ⤷ Sign Up | PRODUCT NAME: VOSORITIDE; REG. NO/DATE: EU/1/21/1577 20210921 |
| 2432489 | LUC00248 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: VOSORITIDE SOUS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/21/1577 20210901 |
| 2432489 | 22C1004 | France | ⤷ Sign Up | PRODUCT NAME: VOSORITIDE; REGISTRATION NO/DATE: EU/1/21/1577 20210901 |
| 2432489 | CA 2022 00004 | Denmark | ⤷ Sign Up | PRODUCT NAME: VOSORITIDE IN ALL FORMS; REG. NO/DATE: EU/1/21/1577 20210901 |
| 2432489 | 122022000008 | Germany | ⤷ Sign Up | PRODUCT NAME: VOSORITID IN ALLEN DURCH DAS GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/21/1577 20210826 |
| 2432489 | C20220003 00351 | Estonia | ⤷ Sign Up | PRODUCT NAME: VOSORITIID;REG NO/DATE: EU/1/21/1577 01.09.2021 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
